Earkart
EARKARTLTD NSE
Earkart
HealthcareNSE: EARKARTLTD BSE: EARKART Medical Equipment
Key Fundamentals
SMEMedical EquipmentHealthcareMarket Cap
₹190 Cr
Volatility
Moderate
P/E Ratio
0
EBITDA
₹8.36 Cr
Return on Equity
34.55%
Debt to Equity
0
Book Value
₹47.02
52W High
₹265.95
52W Low
₹104.35
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company has reduced debt.
- Company is almost debt free.
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 161 days to 237 days
Growth Rate
Revenue Growth
25.09% higher than
3Y
Net Income Growth
-21.16% lower than
3Y
Cash Flow Change
171% lower than
3Y
ROE
47.27% higher than
3Y
ROCE
72.34% lower than
3Y
EBITDA Margin (Avg.)
-32.28% lower than
3Y
Quarterly Results
| Particulars | Sep 2024 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 23.55 | 22.29 | 31.75 |
| Expenses | 18.59 | 19.15 | 26.53 |
| Operating Profit | 4.96 | 3.14 | 5.22 |
| OPM % | 21.06% | 14.09% | 16.44% |
| Other Income | 0.06 | 0.02 | 0.08 |
| Interest | 0.19 | 0.39 | 0.16 |
| Depreciation | 0.16 | 0.23 | 0.43 |
| PBT | 4.67 | 2.54 | 4.71 |
| Tax % | 29.34% | 27.17% | 34.61% |
| Net Profit | 3.31 | 1.85 | 3.08 |
| EPS in Rs | 1.59 | 1.35 | 2.24 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 5.66 | 28.92 | 31.75 | 43.11 | 54.04 |
| Expenses | 5.52 | 27.29 | 28.17 | 33.32 | 45.69 |
| Operating Profit | 0.14 | 1.63 | 3.58 | 9.79 | 8.35 |
| OPM % | 2.47% | 5.64% | 11.28% | 22.71% | 15.45% |
| Other Income | 0.04 | 0.05 | 0.21 | 0.09 | 0.11 |
| Interest | 0.01 | 0.08 | 0.36 | 0.44 | 0.54 |
| Depreciation | 0.06 | 0.15 | 0.19 | 0.42 | 0.66 |
| PBT | 0.11 | 1.45 | 3.24 | 9.02 | 7.26 |
| Tax % | 0% | 9.66% | 5.86% | 23.61% | 31.96% |
| Net Profit | 0.11 | 1.31 | 3.06 | 6.88 | 4.93 |
| EPS in Rs | 22 | 262 | 612 | 6.59 | 3.58 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 0.05 | 10.44 | 13.75 |
| Reserves | 4.72 | 6.49 | 12.97 | 9.48 | 50.59 |
| Borrowings | 0.27 | 1.23 | 4.02 | 4.96 | 0 |
| Other Liabilities | 0.91 | 6.96 | 2.21 | 5.41 | 5.15 |
| Total Liabilities | 5.95 | 14.73 | 19.25 | 30.29 | 69.49 |
| Fixed Assets | 0.22 | 0.25 | 1.06 | 1.17 | 5.88 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 1.46 | 0.1 | 0.19 | 0.83 | 0.15 |
| Other Assets | 4.27 | 14.38 | 18 | 28.29 | 63.46 |
| Total Assets | 5.95 | 14.73 | 19.25 | 30.29 | 69.49 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | -2.83 | -0.3 | -1 | 0.71 | -12.56 |
| Investing | -1.78 | 0.4 | -1.29 | -1.32 | -5.18 |
| Financing | 4.68 | 0.41 | 3.08 | -0.41 | 39.06 |
| Net Cash Flow | 0.07 | 0.51 | 0.8 | -1.01 | 21.32 |
| Free Cash Flow | -3.11 | -0.48 | -1.99 | 0.18 | -17.93 |
| CFO/OP | -2,007 | -17 | -22 | 30 | -122 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 104 | 59.32 | 72.89 | 157 | 142 |
| Inventory Days | 138 | 101 | 113 | 95.52 | 121 |
| Days Payable | 92.17 | 107 | 19.28 | 44.04 | 19.96 |
| Cash Conversion Cycle | 151 | 52.89 | 167 | 209 | 243 |
| Working Capital Days | 192 | 60.83 | 108 | 139 | 237 |
| ROCE % | — | 23.89% | 29.02% | 45.13% | 17.48% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Earkart insights
46 extracted metrics + investor summaries across FY22–FY26.
Documents
1
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
4 May - Postal ballot approved change in utilization of unutilized IPO proceeds; results declared 1 May 2026. 4 May - Postal ballot approved change in utilization of unutilized IPO proceeds; results declared 1 May 2026.
2
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
4 May - Postal ballot approved change in utilization of unutilized IPO proceeds; results declared 1 May 2026. 4 May - Postal ballot approved change in utilization of unutilized IPO proceeds; results declared 1 May 2026.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 15 Apr - Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018
4
Shareholder Meeting/ Postal Ballot- Notice Of Postal Ballot
2 Apr - Postal ballot seeks approval to reallocate unutilized IPO proceeds into working capital, pharma, and acquisitions. 2 Apr - Postal ballot seeks approval to reallocate unutilized IPO proceeds into working capital, pharma, and acquisitions.
5
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Apr - Newspaper Advertisement of the Postal Ballot Notice of the Earkart Limited(''The Company'') 2 Apr - Newspaper Advertisement of the Postal Ballot Notice of the Earkart Limited(''The Company'')
Frequently Asked Questions about Earkart
What does Earkart Limited do?
Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distri...
Where is Earkart Limited (544549) listed?
Earkart Limited trades as EARKARTLTD on the NSE and under code EARKART on the BSE.
Which sector does Earkart Limited belong to?
Earkart Limited is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Earkart Limited?
Earkart Limited has a market capitalisation of ₹189.8 Cr, which places it in the Small Cap band.
What is the PE ratio of Earkart Limited?
Earkart Limited trades at a PE ratio of 0.00, against a book value of ₹47.02 per share.
What is the 52-week high and low of Earkart Limited?
Over the last 52 weeks Earkart Limited has traded between ₹104.35 and ₹265.95.
What is the Return on Equity (ROE) of Earkart Limited?
Earkart Limited reported a return on equity of 34.55%. Its debt-to-equity ratio is 0.00.
Company Information
Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distributing modern digital hearing solutions
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544549.md for Earkart Limited: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.